Targeting cardiovascular complications.
Mayor
Susan
S
D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy; D012307:Risk Factors
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal